These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27118147)

  • 1. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury.
    Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G
    Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
    Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G
    J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.
    Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G
    Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury.
    Chen G; Zhang Y; Liu X; Fang Q; Wang Z; Fu L; Liu Z; Wang Y; Zhao Y; Li X; Liang G
    J Med Chem; 2016 Mar; 59(6):2436-51. PubMed ID: 26937738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.
    Chen L; Jin Y; Chen H; Sun C; Fu W; Zheng L; Lu M; Chen P; Chen G; Zhang Y; Liu Z; Wang Y; Song Z; Liang G
    Eur J Med Chem; 2018 Jan; 143():361-375. PubMed ID: 29202400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.
    Ye J; Guan M; Lu Y; Zhang D; Li C; Li Y; Zhou C
    Eur J Pharmacol; 2019 Jun; 852():151-158. PubMed ID: 30807747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity.
    Zhang Y; Liu Z; Wu J; Bai B; Chen H; Xiao Z; Chen L; Zhao Y; Lum H; Wang Y; Zhang H; Liang G
    Eur J Med Chem; 2018 Mar; 148():291-305. PubMed ID: 29466778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury.
    Chen H; Zhang Y; Zhang W; Liu H; Sun C; Zhang B; Bai B; Wu D; Xiao Z; Lum H; Zhou J; Chen R; Liang G
    Phytomedicine; 2019 Oct; 63():152997. PubMed ID: 31254764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2.
    Wu P; Yan H; Qi J; Jia W; Zhang W; Yao D; Ding C; Zhang Y; Chen M; Cai X
    Drug Dev Res; 2020 Feb; 81(1):85-92. PubMed ID: 31693211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimicrobial peptide LK2(6)A(L) exhibits anti-inflammatory activity by binding to the myeloid differentiation 2 domain and protects against LPS-induced acute lung injury in mice.
    Zhang J; Sun Y; Sun C; Shang D
    Bioorg Chem; 2023 Mar; 132():106376. PubMed ID: 36706531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.
    Chen G; Xiao B; Chen L; Bai B; Zhang Y; Xu Z; Fu L; Liu Z; Li X; Zhao Y; Liang G
    Eur J Med Chem; 2017 Oct; 139():726-740. PubMed ID: 28858767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperlongumine mitigates LPS-induced inflammation and lung injury via targeting MD2/TLR4.
    Tang Y; Zhang W; Wu L; Bai B; Zheng B; Li M; Tang Y; Zhu X; Zhang Y; Wang Y; Zhang B
    Biochem Biophys Res Commun; 2023 Jan; 642():118-127. PubMed ID: 36566563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2.
    Yang L; Luo W; Zhang Q; Hong S; Wang Y; Samorodov AV; Chattipakorn N; Pavlov VN; Liang G
    Phytomedicine; 2021 Dec; 93():153785. PubMed ID: 34638032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2.
    Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y
    Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury.
    Zhang Y; Xu T; Pan Z; Ge X; Sun C; Lu C; Chen H; Xiao Z; Zhang B; Dai Y; Liang G
    Br J Pharmacol; 2018 Mar; 175(5):840-854. PubMed ID: 29243243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and anti-inflammatory evaluation of methyl gallate derivatives as a myeloid differentiation protein 2 inhibitor.
    Qiu Y; Xiao Z; Wang Y; Zhang D; Zhang W; Wang G; Chen W; Liang G; Li X; Zhang Y; Liu Z
    Bioorg Med Chem; 2019 Oct; 27(20):115049. PubMed ID: 31466835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2).
    Zhu W; Wang M; Jin L; Yang B; Bai B; Mutsinze RN; Zuo W; Chattipakorn N; Huh JY; Liang G; Wang Y
    Br J Pharmacol; 2023 Apr; 180(8):1114-1131. PubMed ID: 36480410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
    Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
    Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.